| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 07/01/2003 | US6586627 N-protected/N-substituted-beta-amino hydroxy sulfonates |
| 07/01/2003 | US6586599 Catalyzed coupling reactions of aryl halides with silanes |
| 07/01/2003 | US6586598 α, α-dibromo-α-chloro-acetophenones as synthons |
| 07/01/2003 | US6586592 Bis-arylsulfones |
| 07/01/2003 | US6586475 5-chloro-N-(2-N,N-diethylamino)ethyl)-2- methoxy-4-(1-naphthoylamino)benzamide and prodrugs, used for prevention of neurodegenarative diseases such as Alzheimer's disease |
| 07/01/2003 | US6586466 Carbohydrazide-protease inhibitors |
| 07/01/2003 | US6586454 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 07/01/2003 | US6586433 Anticholesterol agents; antilipemic agents; cardiovascular disorders |
| 07/01/2003 | US6586432 Neurokinin-1 receptor antagonists |
| 07/01/2003 | US6586418 Heteroaryl-phenyl substituted compounds that are inhibitors of trypsin-like serine protease enzymes; anticoagulant for treatment and prevention of thromboembolic disorders |
| 07/01/2003 | US6586187 2-benzyloxycarbonylamino-3-(2-(4-(2-(3-benzylureido)-ethyl) -piperazin-1-yl)acetylamino)-propionic acid, for example; method of synthesis using Wang resins; various uses including anticancer, antiinflammatory and antiviral agents |
| 06/26/2003 | WO2003051855A1 N,n'-disubstituted piperazine compounds and the use of the same as analgesics |
| 06/26/2003 | WO2003051842A2 Compositions decreasing activity of hormone-sensitive lipase |
| 06/26/2003 | WO2003051841A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 06/26/2003 | WO2003051825A1 Human adam-10 inhibitors |
| 06/26/2003 | WO2003051824A1 α-CYANOACRYLATES |
| 06/26/2003 | WO2003051819A1 Substituted 1,5-diaminopentan-3-ol compounds |
| 06/26/2003 | WO2003051369A1 Pharmaceutical containing n, n'-disubstituted piperazine compounds |
| 06/26/2003 | WO2003051353A1 Substituted beta-aminoalcohols used as medicaments |
| 06/26/2003 | WO2003051348A2 Composition, synthesis and therapeutic applications of polyamines |
| 06/26/2003 | WO2003051276A2 Therapeutic heterocycles |
| 06/26/2003 | WO2003002491A3 ENANTIOSELECTIVE TRANSFORMATION OF α, β-UNSATURATED ALDEHYDES USING CHIRAL ORGANIC CATALYSTS |
| 06/26/2003 | US20030120115 Supported cobalt catalysts for nitrile hydrogenations |
| 06/26/2003 | US20030120034 N-(2-hydroxyethyl)-2,4,6-triiodo-5-(2-(2,4,6-triiodo-3-(N-meth yl acetamido)-5-(methylcarbamyl)benzamidoacetamido)-isophthalmic acid, derivatives |
| 06/26/2003 | US20030119902 Novel aminobenzoephenones |
| 06/26/2003 | US20030119876 Compounds for the treatment of protozoal diseases |
| 06/26/2003 | US20030119851 In the treatment or prevention of psychotic disorders such as schizophrenia psychotic depression, mania and other central nervous system diseases |
| 06/26/2003 | US20030119833 Treating cardiovascular diseases |
| 06/26/2003 | US20030119827 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases |
| 06/26/2003 | US20030119819 Anticancer agents |
| 06/26/2003 | US20030119803 In particular N-epsilon-amino acid substituted L-lysine derivatives possessing aspartyl protease inhibitory properties. |
| 06/26/2003 | US20030119788 N-cyanomethyl carbonamides and sulfonamides which are cysteine protease, particularly cathepsin K, inhibitors |
| 06/26/2003 | CA2510128A1 Composition, synthesis and therapeutic applications of polyamines |
| 06/26/2003 | CA2473938A1 Human adam-10 inhibitors |
| 06/26/2003 | CA2473877A1 Substituted beta-aminoalcohols as pharmaceutical preparations |
| 06/26/2003 | CA2471500A1 Substituted 1,5-diaminopentan-3-ol compounds |
| 06/26/2003 | CA2469944A1 Medicaments comprising n, n'-disubstituted piperazine compounds and their use |
| 06/26/2003 | CA2469716A1 .alpha.-cyanoacrylates |
| 06/26/2003 | CA2468978A1 Therapeutic heterocycles |
| 06/26/2003 | CA2468413A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 06/25/2003 | EP1320520A1 Sulfonylguanidine |
| 06/25/2003 | EP1025086B1 Benzamidine derivatives as factor xa inhibitors |
| 06/25/2003 | CN1426412A Novel compounds |
| 06/25/2003 | CN1426395A Inhibitors of dipeptidyl peptidase IV |
| 06/25/2003 | CN1426394A Novel compounds |
| 06/25/2003 | CN1426393A Novel compounds |
| 06/25/2003 | CN1426392A Propenecarboxylic acid amidoxime derivatives, process for preparation thereof, and pharmaceutical compositions containing same |
| 06/25/2003 | CN1112361C Process for preparing N-formyl morpholine |
| 06/24/2003 | US6583286 Method for hydrogenating unsaturated heterocyclic compounds |
| 06/24/2003 | US6583282 Formation of a urea by reacting an aromatic carbamate with a aromatic amine |
| 06/24/2003 | US6583183 Substituted n-phenyl-n-fused-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 06/24/2003 | US6583180 Glucocorticoid receptor modulators |
| 06/24/2003 | US6583179 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone |
| 06/24/2003 | US6583165 Anticarcinogenic, -inflammatory and -proliferative agents; viricides; bactericides; vascular restenosis, autoimmune diseases; psoriasis; anticolesterol and -lipemic agents |
| 06/24/2003 | CA2288910C Pyrazolopyrimidinones for sexual dysfunction |
| 06/24/2003 | CA2126337C 2-amino-1,3-propanediol compound and immunosuppressant |
| 06/19/2003 | WO2003050099A1 Phenylalkynes |
| 06/19/2003 | WO2003049690A2 Hiv integrase inhibitors |
| 06/19/2003 | US20030114665 Such as 7-(((5-amino-1,2,4-thiadiazol-3-yl)-(Z)-(fluoro-methoxyimino)acetyl)amino)-3-(imino-1-piperazinylmethyl) methylhydrazono)methyl-3-cephem-4-carboxylic acid |
| 06/19/2003 | US20030114521 Oxamic acids and derivatives as thyroid receptor ligands |
| 06/19/2003 | US20030114508 Fused imidazolium derivatives |
| 06/19/2003 | US20030114496 Treatment or prevention of Alzheimer's disease |
| 06/19/2003 | US20030114490 New phenylalanine derivatives |
| 06/19/2003 | US20030114454 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 06/19/2003 | US20030114442 Reducing concentration of blood lipoproteins |
| 06/19/2003 | US20030114440 Compositions and methods of treatment for conditions responsive to testosterone elevation |
| 06/19/2003 | US20030114427 Remedies and/or preventives for nervous system disorders |
| 06/19/2003 | US20030114423 Arylamines as inhibitors of chemokine binding to US28 |
| 06/19/2003 | CA2469893A1 Phenylalkynes |
| 06/18/2003 | EP1318980A2 Hydroxamate derivatives useful as deacetylase inhibitors |
| 06/18/2003 | EP1318978A2 N-acylsulfonamide apoptosis promoters |
| 06/18/2003 | EP1318977A1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof |
| 06/18/2003 | EP1318811A1 Cyclopentyl modulators of chemokine receptor activity |
| 06/18/2003 | EP1183248B1 Non-linear optical devices and materials therefor |
| 06/18/2003 | EP1140829A4 Contrast media for angiography |
| 06/18/2003 | EP1082297B1 Substituted dithio-bis-nitrobenzenes and their applications |
| 06/18/2003 | CN1425005A Cyclic quaternary ammonium compound |
| 06/18/2003 | CN1424910A IL-8 receptor antagonists |
| 06/18/2003 | CN1111520C Matrix metalloprotease inhibitors |
| 06/17/2003 | US6579890 Matrix metalloprotease inhibitors |
| 06/17/2003 | US6579881 Muscle relaxants, antiserotonine agent |
| 06/17/2003 | US6579872 Bezamide derivatives for the treatment of diseases mediated by cytokines |
| 06/17/2003 | US6579870 5-(1,4-diazepan-1-yl)-2-((3 -fluorophenyl)sulfonyl)phenylamine for example; treatment of diseases or disorders of the central nervous system; modulation of serotonin (5-HT) activity |
| 06/17/2003 | US6579823 Group 8-10 metal complex comprising a bidentate or variable denticity ligand; polymerization of olefins |
| 06/17/2003 | CA2059044C The use of n-(aminoalkyl) pyrrolidines as catalysts for the polyisocyanate polyaddition process |
| 06/12/2003 | WO2003048158A1 Glycinamides as factor xa inhibitors |
| 06/12/2003 | WO2003048121A1 Therapeutic benzamide derivatives |
| 06/12/2003 | WO2003048118A1 5-ht7 receptor antagonists |
| 06/12/2003 | WO2003048115A1 Bacterial enzyme inhibitors |
| 06/12/2003 | WO2003048109A1 Novel glucagon antagonists |
| 06/12/2003 | WO2003048108A2 Compounds for treatment of inflammation, diabetes and related disorders |
| 06/12/2003 | WO2003048081A2 Glycinamides as factor xa inhibitors |
| 06/12/2003 | WO2003047625A1 Neural transmission promoters |
| 06/12/2003 | WO2003047575A1 Therapeutic benzamide derivatives |
| 06/12/2003 | WO2003047568A1 N-aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity |
| 06/12/2003 | WO2003047515A2 P2x7 receptor antagonists |
| 06/12/2003 | WO2002047679A3 Nonpeptide agonists and antagonists of vasopressin receptors |
| 06/12/2003 | WO2002017712A3 Disubstituted benzenes as insecticides |
| 06/12/2003 | US20030109718 Enantioselective transformation of alpha, beta-unsaturated aldehydes using chiral organic catalysts |
| 06/12/2003 | US20030109703 Antiinflammatory agents; autoimmune disease |